Navigation Links
NutraCea Appoints Financial Relations Board as New Investor Relations Firm
Date:10/24/2007

andard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com.

About Financial Relations Board

For more than 40 years, the Financial Relations Board has been one of the nation's leaders for investor relations and financial communications. The firm offers a full array of services including deep expertise in corporate positioning and communication, investment community targeting (market intelligence), financial media relations, shareholder management services, valuation analysis and the company's industry-leading Strategy Consulting Group. Financial Relations Board works alongside companies of all sizes, from established Fortune 100 brands to mid-size and micro-cap companies, pre-IPOs and the newly public. Headquartered in Chicago, the firm has full-service offices in New York, Los Angeles, San Francisco and Washington, D.C. Financial Relations Board is part of the Interpublic Group of Companies (NYSE: IPG). For more information on Financial Relations Board, visit http://www.frbir.com.

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future communications with the investment community regarding NutraCea. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The
'/>"/>

SOURCE NutraCea
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
2. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
3. Health conditions and patient treatment affected by a financial crunch
4. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
5. Bird Flu: Fear of the Unknown Could Put Financial Markets in a Soup
6. Huge financial losses due to Bird flu scare!
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Elective Surgery - the Financial Whipping Boy
9. British Hospitals Face Financial Crisis
10. Kidney donors do not realize financial gains
11. Bird-Flu Pandemic will be a Huge Financial Drain, says World Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Va., Jan. 8 Today, the... along with several national leadership organizati...nciples of hospice care and protection of the Medi...ogether in sharing this unified message about end-...ce and Palliative Medicine, Hospice and Palliative...
(Date:1/8/2009)...sugar sitting on the surface of cancer cells are k...oth treating and stopping the spread of certain ty...ostate, breast, ovarian and lung, among others. A...he Gateway for Cancer Research, an Illinois-based ...Franco, M.D., Ph.D., and her co-workers at the Moo...
(Date:1/8/2009)...pts Prenatal Solution Key Factor in Decision for F...RLANDO, Fla., Jan. 8 All...LLC, one of the largest multi-specialty group prac... the Allscripts Enterprise(TM) Electronic Health R...cians in 18 offices across Central Florida. , ...
(Date:1/8/2009)... local dance students will dance to raise money fo...IS, Jan. 8 , , , WHO: ...show off their talent in the 3rd annual Dance, ...ance Arts Centre. The, event will..., Participants raise money throu...
Breaking Medicine News(10 mins):Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Dance With Courage to Benefit Camp Courage 2
...ity is certainly one of the risk factors associate...hospitalization and mortality. Time and again, man...p between body shape // and heart disease. With th...y be it is time, people to reshape themselves. Th...
...rtment of Health and Human Services (HHS) plans to...n people has come under strong criticism for the p... America and other critics who say that the stocks...t least 100 million vaccine stocks in order to eff...
...her it's triggered by the monotone of an instructo...at all ages and grade levels sometimes have troubl...nd a way to combat the sleepiness // and to keep s...sn't have anything to do with caffeine or high-sug...
... massive AIDS/HIV control drive, Chinese authoriti...bution at hotels and public entertainment places. ...ndoms // using a special fund created for the purp...aid on Thursday. The condoms will be distributed ...
Other Medicine News:Health News:Health and Human Services stockpiles 20 million bird flu Vaccines 2Health News:China To Distribute Free Condoms To Combat AIDS/HIV 2
(Date:1/6/2009)...swire-USNewswire/ -- The Michael J. Fox Foundation...ustry research teams for pre-clinical research on ..., , The funding was awarded under the Foundatio...ogram, first launched in 2006, supports and bolste...h. TDI is part of MJFF,s focus on ,de-risking,...
(Date:1/6/2009)...6 Cequent Pharmaceuticals, a pione... RNAi-based treatments to prevent and treat human ...ompleted a successful toxicology study of its cand...apeutic targeting the primary oncogene (beta-caten...). FAP is an inherited gastrointestinal disease th...
(Date:1/6/2009)...ary 6 , - Early R...n Until,December 2011 , - Expansion of the...iscovery in Ophthalmology , - Revised Comme...ublicenses to a Third Party , ExonHit The...nforcement,of its existing drug discovery collabo...
(Date:1/5/2009)... 5 Micromet, Inc.,(Nasd...ng novel, proprietary,antibodies for the treatmen...,provides an outlook on key events anticipated fo...ovide an update on its research and development,p... 12 to 16, 2009: Update on several preclinical BiT...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza 28H5N1 29 Vaccine 2547 1Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza 28H5N1 29 Vaccine 2547 2Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza 28H5N1 29 Vaccine 2547 3DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix 28TM 29 or Aspirin 2544 1DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix 28TM 29 or Aspirin 2544 2DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix 28TM 29 or Aspirin 2544 3DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix 28TM 29 or Aspirin 2544 4Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 22925 1Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 22925 2MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real Life Medical Mysteries on Discovery Health 22922 1MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real Life Medical Mysteries on Discovery Health 22922 2MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real Life Medical Mysteries on Discovery Health 22922 3
...USINESS WIRE)--Mar 19, 2007 - Avid,Radiopharmaceut...aging company, today announced the presentation of...-1/ZK (AV-1), a novel,radiopharmaceutical for posi...plaques in patients with Alzheimer,s disease. Prin...n Hospital of,Melbourne, a leading investigator in...
...de First U.S. Clinical Data on XIENCE V Everolimus...ient Follow-Up,Results from the ABSORB Bioabsorb...rch 19, 2007 /PRNewswire-FirstCall/ --,Abbott wi...oad,vascular portfolio and pipeline during a num...essions at the of Cardiology,s 56th,Annual Scien...
Other Medicine Technology:Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 2Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 3Avid Announces Results of AV-1 Molecular Imaging Agent for,Alzheimer's Disease Presented at AD/PD Meeting 4Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 2Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 3Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 4Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 5
Provide 1.5mm protection throughout. Six durable, attractive vinyl coverings are available. Lead glass window factory installed. Larger window available.
Swing-Arm™ Scatter Shield® provides lower extremity protection for personnel close to the tube. 24"Wx32"L lead shield swings 180 along table. Ideal for cardiac cath, special studies, electr
Front Protection with attached Belt Guard, Built-in Back Support; Buckle Closure
Surgical Drop-Off Apron
Medicine Products: